Switzerland - Zurich SARS-CoV-2 Cohort: COVID-19 Hospitalizations, Symptoms, Complications, Quality of Life, and Mental Wellbeing 2020-2021

Nav

General Info

Email
Print

Geography

Switzerland (CHE)

Zürich

Coverage type

Subnational

Time period covered

08/2020 - 01/2021

Series or system

Switzerland - Zurich SARS-CoV-2 Cohort Study on Long Covid

Data type

Individual
Longitudinal

Keywords

Anxiety, Breathing difficulty, COVID-19, Cognitive assessment, Dermatitis, Disease outbreaks, EQ-5D, Fatigue, Headache, Health status, Hospitals, Intensive care units, Long COVID, Loss of smell, Loss of taste, Mental health diagnostic interview, Mental health symptoms, Pain, Symptoms

Citation

Contributors

Health Directorate Zurich (Switzerland)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich

University of Zurich

Funders

University of Zurich Foundation

Health Directorate Zurich (Switzerland)

Federal Office of Public Health (Switzerland)

Suggested citation

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Health Directorate Zurich (Switzerland), University of Zurich. Switzerland - Zurich SARS-CoV-2 Cohort: COVID-19 Hospitalizations, Symptoms, Complications, Quality of Life, and Mental Wellbeing 2020-2021.

GHDx Entry last modified on: Aug 21, 2024